• European Partnership for Personalised Medicine - EP PerMed
• EP PerMed Information Day on May 31, 2021
• Draft Concept Paper “European Partnership for Personalised Medicine - EP PerMed”
• Guideline Paper supports set up of EP PerMed
• ERA Learn Workshops

Within the EU’s 9th Framework Programme for Research and Innovation, Horizon Europe, the set-up of a co-funded European Partnership for Personalised Medicine (EP PerMed) is proposed. Its aim is to align and promote regional and national priority setting and funding for research and implementation projects in the area of personalised medicine between the EU Member States, regions and associated countries as well as international partner countries.

Over the last years, remarkable progress was made in the field of personalised medicine by a large number of international, pan-European, national as well as regional and inter-regional activities and initiatives. But to further develop and foster promising personalised medicine approaches and the further implementation in healthcare, there is a need of an even closer collaboration which could be achieved by a European Partnership for Personalised Medicine under Horizon Europe centralising the different actions currently existing under one umbrella structure.

The initiatives ICPerMed and ERA PerMed promote the establishment of this European Partnership. They jointly published a draft concept paper informing about EP PerMed’s objectives and expected impacts as well as a guidance document, serving as a guide for decision-makers and stakeholders in the preparation of EP PerMed.

The start of the European Partnership for Personalised Medicine is foreseen in the second phase of the work program (2023). The Member States consultation, organised by the European Commission, is expected to take place in 2021. This newsletter provides an overview about current activities of ICPerMed and ERA PerMed regarding this new partnership. More information can be found in a dedicated EP PerMed section on the ICPerMed website.

ICPerMed and ERA PerMed invite all interested stakeholders, in particular national and regional authorities (as ministries, funders, etc.), to the virtual information event

“European Partnership for Personalised Medicine calling for national and regional involvement”

ICPerMed and ERA PerMed will inform about their joint proposal for EP PerMed, its objectives, activities and expected impacts, and the overall framework for engagement in this partnership.

Further, ICPerMed and ERA PerMed would like to engage with national and regional authorities as well as funders and stakeholders interested in promoting and implementing personalised medicine approaches in their countries and regions, with the overall aim to foster personalised diagnostics, therapies and prevention for the benefit of patients and citizens.

The virtual event will take place on May 31, 2021 (1pm – 4.30pm CEST).

If you are interested to join this event and to discuss the national and regional involvement in EP PerMed, please register here.

ICPerMed and ERA PerMed published a jointly developed draft concept paper for EP PerMed.

With this paper, ICPerMed and ERA PerMed underline the need for establishing a European Partnership for Personalised Medicine and propose their vision for EP PerMed, its objectives, its activities and its expected impacts. The paper also outlines the composition of the partnership consortium and its interaction with the personalised medicine ecosystem at European and international level.

The current version of the draft concept paper was provided to the European Commission after receiving the approval by the over 50 organisations from more than 30 countries (of which 24 European countries) involved in ICPerMed and ERA PerMed.

The paper received valuable European Commission input but does not represent an official document developed and approved by the European Commission. The paper is not the official partnership proposal.

ICPerMed and ERA PerMed further published a jointly developed guide for the next steps towards EP PerMed.

The guideline paper is intended to provide support for representatives of national and regional authorities, ministries, funders and policy makers and the personalised medicine stakeholder community. The path towards EP PerMed is work in progress. Thus, this guideline is a dynamic document that will be updated when new information or developments become available.

In addition, topic-specific one-pagers will soon be available for areas of action listed in the guideline paper.

With this document, ICPerMed and ERA PerMed aim to promote EP PerMed. Information on EP PerMed’s preparations and recommendations for regional/national organisations in preparation of this partnership are provided. The aim is to foster participation of interested organisations and to help organising the baselines for preparations on the regional and national level, in order to mobilise national budget commitments and receive stakeholder input for the creation of the partnership.

A support for the transition between Horizon 2020 and Horizon Europe is provided by ERA Learn. For this purpose, several workshops have been and will be organised:

• 04/03/2021, Preparing cofunded European Partnerships
• 22/04/2021, Online Workshop on Globalisation of European Partnerships
• 28/04/2021, ERA-LEARN Webinar on Widening in Partnerships